Selected research
Market Analysis & Forecast
Global Toxicological Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Toxicological Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Toxicological Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Toxicological Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Toxicological Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Toxicological Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Toxicological Testing include Fraunhofer ITEM, Microbac Laboratories, Jordi Labs, Eurofins Scientific, Redwood Toxicology Laboratory, Abbott Toxicology, Charles River, MedTox and Drugscan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Toxicological Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Toxicological Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Toxicological Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Toxicological Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Toxicological Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Toxicological Testing revenue, projected growth trends, production technology, application and end-user industry.
Toxicological Testing Segment by Company
Fraunhofer ITEM
Microbac Laboratories
Jordi Labs
Eurofins Scientific
Redwood Toxicology Laboratory
Abbott Toxicology
Charles River
MedTox
Drugscan
Bio Rad Laboratories Inc
Intertek
BICO Group AB
AquaTox Testing & Consulting
BioIVT LLC
Charles River Laboratories
CompuDrug Ltd.
Evotec SE
Ingenza Ltd.
Toxicological Testing Segment by Type
Acute Toxicity Test
Subacute Toxicity Testing
Chronic Toxicity Test
Allergy Testing
Mutagenicity Test
Long Term Accumulation Test
Toxicological Testing Segment by Application
Hospital
Clinic
Research Institutions
Toxicological Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxicological Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Toxicological Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxicological Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Toxicological Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Toxicological Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Toxicological Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Acute Toxicity Test
- Subacute Toxicity Testing
- Chronic Toxicity Test
- Allergy Testing
- Mutagenicity Test
- Long Term Accumulation Test
Applications
- Hospital
- Clinic
- Research Institutions
Companies covered
- Fraunhofer ITEM
- Microbac Laboratories
- Jordi Labs
- Eurofins Scientific
- Redwood Toxicology Laboratory
- Abbott Toxicology
- Charles River
- MedTox
- Drugscan
- Bio Rad Laboratories Inc
- Intertek
- BICO Group AB
- AquaTox Testing & Consulting
- BioIVT LLC
- Charles River Laboratories
- CompuDrug Ltd.
- Evotec SE
- Ingenza Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Toxicological Testing Market by Type
- 1.2.1 Global Toxicological Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Acute Toxicity Test
- 1.2.3 Subacute Toxicity Testing
- 1.2.4 Chronic Toxicity Test
- 1.2.5 Allergy Testing
- 1.2.6 Mutagenicity Test
- 1.2.7 Long Term Accumulation Test
- 1.3 Toxicological Testing Market by Application
- 1.3.1 Global Toxicological Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Research Institutions
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Toxicological Testing Market Dynamics
- 2.1 Toxicological Testing Industry Trends
- 2.2 Toxicological Testing Industry Drivers
- 2.3 Toxicological Testing Industry Opportunities and Challenges
- 2.4 Toxicological Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Toxicological Testing Market Perspective (2021-2032)
- 3.2 Global Toxicological Testing Growth Trends by Region
- 3.2.1 Global Toxicological Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Toxicological Testing Market Size by Region (2021-2026)
- 3.2.3 Global Toxicological Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Toxicological Testing Revenue by Players
- 4.1.1 Global Toxicological Testing Revenue by Players (2021-2026)
- 4.1.2 Global Toxicological Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Toxicological Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Toxicological Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Toxicological Testing Key Players Headquarters & Area Served
- 4.4 Global Toxicological Testing Players, Product Type & Application
- 4.5 Global Toxicological Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Toxicological Testing Market CR5 and HHI
- 4.6.3 2025 Toxicological Testing Tier 1, Tier 2, and Tier 3
5 Toxicological Testing Market Size by Type
- 5.1 Global Toxicological Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Toxicological Testing Revenue by Type (2021-2032)
- 5.3 Global Toxicological Testing Revenue Market Share by Type (2021-2032)
6 Toxicological Testing Market Size by Application
- 6.1 Global Toxicological Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Toxicological Testing Revenue by Application (2021-2032)
- 6.3 Global Toxicological Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Fraunhofer ITEM
- 7.1.1 Fraunhofer ITEM Company Information
- 7.1.2 Fraunhofer ITEM Business Overview
- 7.1.3 Fraunhofer ITEM Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Fraunhofer ITEM Toxicological Testing Product Portfolio
- 7.1.5 Fraunhofer ITEM Recent Developments
- 7.2 Microbac Laboratories
- 7.2.1 Microbac Laboratories Company Information
- 7.2.2 Microbac Laboratories Business Overview
- 7.2.3 Microbac Laboratories Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Microbac Laboratories Toxicological Testing Product Portfolio
- 7.2.5 Microbac Laboratories Recent Developments
- 7.3 Jordi Labs
- 7.3.1 Jordi Labs Company Information
- 7.3.2 Jordi Labs Business Overview
- 7.3.3 Jordi Labs Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 Jordi Labs Toxicological Testing Product Portfolio
- 7.3.5 Jordi Labs Recent Developments
- 7.4 Eurofins Scientific
- 7.4.1 Eurofins Scientific Company Information
- 7.4.2 Eurofins Scientific Business Overview
- 7.4.3 Eurofins Scientific Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Eurofins Scientific Toxicological Testing Product Portfolio
- 7.4.5 Eurofins Scientific Recent Developments
- 7.5 Redwood Toxicology Laboratory
- 7.5.1 Redwood Toxicology Laboratory Company Information
- 7.5.2 Redwood Toxicology Laboratory Business Overview
- 7.5.3 Redwood Toxicology Laboratory Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 Redwood Toxicology Laboratory Toxicological Testing Product Portfolio
- 7.5.5 Redwood Toxicology Laboratory Recent Developments
- 7.6 Abbott Toxicology
- 7.6.1 Abbott Toxicology Company Information
- 7.6.2 Abbott Toxicology Business Overview
- 7.6.3 Abbott Toxicology Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Abbott Toxicology Toxicological Testing Product Portfolio
- 7.6.5 Abbott Toxicology Recent Developments
- 7.7 Charles River
- 7.7.1 Charles River Company Information
- 7.7.2 Charles River Business Overview
- 7.7.3 Charles River Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Charles River Toxicological Testing Product Portfolio
- 7.7.5 Charles River Recent Developments
- 7.8 MedTox
- 7.8.1 MedTox Company Information
- 7.8.2 MedTox Business Overview
- 7.8.3 MedTox Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 MedTox Toxicological Testing Product Portfolio
- 7.8.5 MedTox Recent Developments
- 7.9 Drugscan
- 7.9.1 Drugscan Company Information
- 7.9.2 Drugscan Business Overview
- 7.9.3 Drugscan Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 Drugscan Toxicological Testing Product Portfolio
- 7.9.5 Drugscan Recent Developments
- 7.10 Bio Rad Laboratories Inc
- 7.10.1 Bio Rad Laboratories Inc Company Information
- 7.10.2 Bio Rad Laboratories Inc Business Overview
- 7.10.3 Bio Rad Laboratories Inc Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Bio Rad Laboratories Inc Toxicological Testing Product Portfolio
- 7.10.5 Bio Rad Laboratories Inc Recent Developments
- 7.11 Intertek
- 7.11.1 Intertek Company Information
- 7.11.2 Intertek Business Overview
- 7.11.3 Intertek Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 Intertek Toxicological Testing Product Portfolio
- 7.11.5 Intertek Recent Developments
- 7.12 BICO Group AB
- 7.12.1 BICO Group AB Company Information
- 7.12.2 BICO Group AB Business Overview
- 7.12.3 BICO Group AB Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 BICO Group AB Toxicological Testing Product Portfolio
- 7.12.5 BICO Group AB Recent Developments
- 7.13 AquaTox Testing & Consulting
- 7.13.1 AquaTox Testing & Consulting Company Information
- 7.13.2 AquaTox Testing & Consulting Business Overview
- 7.13.3 AquaTox Testing & Consulting Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.13.4 AquaTox Testing & Consulting Toxicological Testing Product Portfolio
- 7.13.5 AquaTox Testing & Consulting Recent Developments
- 7.14 BioIVT LLC
- 7.14.1 BioIVT LLC Company Information
- 7.14.2 BioIVT LLC Business Overview
- 7.14.3 BioIVT LLC Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.14.4 BioIVT LLC Toxicological Testing Product Portfolio
- 7.14.5 BioIVT LLC Recent Developments
- 7.15 Charles River Laboratories
- 7.15.1 Charles River Laboratories Company Information
- 7.15.2 Charles River Laboratories Business Overview
- 7.15.3 Charles River Laboratories Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.15.4 Charles River Laboratories Toxicological Testing Product Portfolio
- 7.15.5 Charles River Laboratories Recent Developments
- 7.16 CompuDrug Ltd.
- 7.16.1 CompuDrug Ltd. Company Information
- 7.16.2 CompuDrug Ltd. Business Overview
- 7.16.3 CompuDrug Ltd. Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.16.4 CompuDrug Ltd. Toxicological Testing Product Portfolio
- 7.16.5 CompuDrug Ltd. Recent Developments
- 7.17 Evotec SE
- 7.17.1 Evotec SE Company Information
- 7.17.2 Evotec SE Business Overview
- 7.17.3 Evotec SE Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.17.4 Evotec SE Toxicological Testing Product Portfolio
- 7.17.5 Evotec SE Recent Developments
- 7.18 Ingenza Ltd.
- 7.18.1 Ingenza Ltd. Company Information
- 7.18.2 Ingenza Ltd. Business Overview
- 7.18.3 Ingenza Ltd. Toxicological Testing Revenue and Gross Margin (2021-2026)
- 7.18.4 Ingenza Ltd. Toxicological Testing Product Portfolio
- 7.18.5 Ingenza Ltd. Recent Developments
8 North America
- 8.1 North America Toxicological Testing Revenue (2021-2032)
- 8.2 North America Toxicological Testing Revenue by Type (2021-2032)
- 8.2.1 North America Toxicological Testing Revenue by Type (2021-2026)
- 8.2.2 North America Toxicological Testing Revenue by Type (2027-2032)
- 8.3 North America Toxicological Testing Revenue Share by Type (2021-2032)
- 8.4 North America Toxicological Testing Revenue by Application (2021-2032)
- 8.4.1 North America Toxicological Testing Revenue by Application (2021-2026)
- 8.4.2 North America Toxicological Testing Revenue by Application (2027-2032)
- 8.5 North America Toxicological Testing Revenue Share by Application (2021-2032)
- 8.6 North America Toxicological Testing Revenue by Country
- 8.6.1 North America Toxicological Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Toxicological Testing Revenue by Country (2021-2026)
- 8.6.3 North America Toxicological Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Toxicological Testing Revenue (2021-2032)
- 9.2 Europe Toxicological Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Toxicological Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Toxicological Testing Revenue by Type (2027-2032)
- 9.3 Europe Toxicological Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Toxicological Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Toxicological Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Toxicological Testing Revenue by Application (2027-2032)
- 9.5 Europe Toxicological Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Toxicological Testing Revenue by Country
- 9.6.1 Europe Toxicological Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Toxicological Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Toxicological Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Toxicological Testing Revenue (2021-2032)
- 10.2 China Toxicological Testing Revenue by Type (2021-2032)
- 10.2.1 China Toxicological Testing Revenue by Type (2021-2026)
- 10.2.2 China Toxicological Testing Revenue by Type (2027-2032)
- 10.3 China Toxicological Testing Revenue Share by Type (2021-2032)
- 10.4 China Toxicological Testing Revenue by Application (2021-2032)
- 10.4.1 China Toxicological Testing Revenue by Application (2021-2026)
- 10.4.2 China Toxicological Testing Revenue by Application (2027-2032)
- 10.5 China Toxicological Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Toxicological Testing Revenue (2021-2032)
- 11.2 Asia Toxicological Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Toxicological Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Toxicological Testing Revenue by Type (2027-2032)
- 11.3 Asia Toxicological Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Toxicological Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Toxicological Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Toxicological Testing Revenue by Application (2027-2032)
- 11.5 Asia Toxicological Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Toxicological Testing Revenue by Country
- 11.6.1 Asia Toxicological Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Toxicological Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Toxicological Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Toxicological Testing Revenue (2021-2032)
- 12.2 SAMEA Toxicological Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Toxicological Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Toxicological Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Toxicological Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Toxicological Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Toxicological Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Toxicological Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Toxicological Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Toxicological Testing Revenue by Country
- 12.6.1 SAMEA Toxicological Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Toxicological Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Toxicological Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst